In our study, CDK7 inhibition reduced the migration and invasion activity of ICC cells, and suppressed the c‐Met signaling pathway, whose aberrant activation is implicated in metastasis 18. Here, CDK7 is linked to intrahepatic cholangiocarcinoma.